Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI – Get Free Report) rose 7.8% on Thursday . The company traded as high as $12.60 and last traded at $12.49. Approximately 726,596 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 866,732 shares. The stock had previously closed at $11.59.
Analysts Set New Price Targets
A number of research firms have issued reports on LMRI. Weiss Ratings upgraded Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a report on Thursday, June 25th. Barclays reduced their price objective on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Finally, Wall Street Zen upgraded Lumexa Imaging from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.
Read Our Latest Stock Report on LMRI
Lumexa Imaging Stock Up 7.1%
Insider Transactions at Lumexa Imaging
In other Lumexa Imaging news, Director Brett Brodnax purchased 35,000 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were purchased at an average cost of $7.25 per share, with a total value of $253,750.00. Following the transaction, the director directly owned 62,027 shares of the company’s stock, valued at $449,695.75. This represents a 129.50% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.70% of the company’s stock.
Hedge Funds Weigh In On Lumexa Imaging
Hedge funds have recently modified their holdings of the stock. Monashee Investment Management LLC bought a new stake in Lumexa Imaging during the fourth quarter worth about $2,775,000. Seven Grand Managers LLC bought a new position in Lumexa Imaging in the fourth quarter valued at approximately $11,942,000. Element Capital Management LLC acquired a new position in shares of Lumexa Imaging during the 4th quarter worth approximately $1,616,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Lumexa Imaging during the 4th quarter worth approximately $27,750,000. Finally, Assetmark Inc. bought a new stake in shares of Lumexa Imaging during the 4th quarter worth approximately $36,000.
About Lumexa Imaging
We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).
See Also
- Five stocks we like better than Lumexa Imaging
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Lumexa Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumexa Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
